A new short-term combination therapy of leprosy.
Report on the results with a new therapy with a complex combination (rifampicin + co-trimoxazole + isoniazid) for the treatment of leprosy. High tolerance. Duration of treatment 2 months.
Freerksen
E
E
Departamento de Lepra, Asunción, Paraguay.
Alvarenga
A E
AE
Leguizamon
O
O
de Morra
M V
MV
Reyes
L A
LA
von Ballestrem
W
W
D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D004893:Erythema Nodosum / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D007917:Leprostatic Agents / Q000627:therapeutic use*; D015439:Leprosy, Borderline / Q000188:drug therapy; D015440:Leprosy, Lepromatous / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000627:therapeutic use*
D007917:Leprostatic Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D007538:Isoniazid; D012293:Rifampin